Uniper SRL
The score of Uniper shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +9 % Total assets +9 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Uniper's annual accounts
Filed annual accounts
- Year ended 31 Mar 2025filed on 19 Nov 2025
- Year ended 31 Mar 2024filed on 08 Nov 2024
- Year ended 31 Mar 2023filed on 27 Oct 2023
- Year ended 31 Mar 2022filed on 10 Nov 2022
- Year ended 31 Mar 2021filed on 30 Sep 2021
Uniper's financial analysis
- Solvency79.6%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Uniper
Uniper's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0443.337.609
- VAT number
- BE0443337609
- Peppol
- Registered · 0208:0443337609 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 14 Feb 1991
- Registered office
- 9850 Deinze
- Latest accounts
- 2025 · filed on 19 Nov 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Uniper (SRL) has been based in Deinze since 1991, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 2,678 € and equity of 220,933 €; its revenue is not published. Its solvency stands at 79.6%, above the median of its sector (44.2%).
Companies similar to Uniper
Companies in the same business, of comparable size and area, outside its group.
- Pharmacy Ghent Retail sale of pharmaceutical products Ghent · balance sheet 273,292 €
- Pharmacie Clemenceau Retail sale of pharmaceutical products Anderlecht · balance sheet 278,102 €
- Oosterapotheek Retail sale of pharmaceutical products Antwerp · balance sheet 275,743 €
- Apotheek Verdonck - Verpoort Retail sale of pharmaceutical products Tielt · balance sheet 275,270 €
- Gezondheidscentrum Vlierbeek Retail sale of pharmaceutical products Holsbeek · balance sheet 273,099 €
- Pharma-Seilles Retail sale of pharmaceutical products Andenne · balance sheet 283,948 €
- Medipharm Anderlecht Retail sale of pharmaceutical products Evere · balance sheet 285,622 €
- De Baere OLV Retail sale of pharmaceutical products Roosdaal · balance sheet 269,784 €
Frequently asked questions about Uniper
What is the revenue of Uniper?
Uniper files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Uniper?
In Belgium, the VAT number is the company number prefixed with BE: BE0443337609 for Uniper, if the company is VAT-registered. Its company number (CBE) is 0443.337.609.
Where is the registered office of Uniper?
According to the CBE register, the registered office of Uniper is in 9850 Deinze.
What is the equity of Uniper?
At the close of the 2025 financial year, the equity of Uniper amounts to 220,933 €, a solvency of 79.6% of total assets.
Who manages Uniper?
The register lists 2 active mandates at Uniper. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Uniper
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →